doi: 10.1097/TP.0000000000003764.
Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration
Affiliations
- PMID: 33741844
- DOI: 10.1097/TP.0000000000003764
Item in Clipboard
Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration
Transplantation.
.
No abstract available
Conflict of interest statement
The authors declare no funding or conflicts of interest.
Similar articles
-
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.J Am Soc Nephrol. 2021 Sep;32(9):2153-2158. doi: 10.1681/ASN.2021040490. Epub 2021 Jun 16. J Am Soc Nephrol. 2021. PMID: 34135083 Free PMC article.
-
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.Clin Microbiol Infect. 2021 Oct;27(10):1529-1530. doi: 10.1016/j.cmi.2021.06.022. Epub 2021 Jun 27. Clin Microbiol Infect. 2021. PMID: 34192576 Free PMC article. No abstract available.
-
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15. Ann Intern Med. 2021. PMID: 34125572 Free PMC article. No abstract available.
-
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.Microbes Infect. 2020 Nov-Dec;22(10):515-524. doi: 10.1016/j.micinf.2020.09.004. Epub 2020 Sep 19. Microbes Infect. 2020. PMID: 32961274 Free PMC article. Review.
-
COVID-19 in an HIV-positive kidney transplant recipient.Transpl Infect Dis. 2020 Oct;22(5):e13338. doi: 10.1111/tid.13338. Epub 2020 Aug 2. Transpl Infect Dis. 2020. PMID: 32453483 Free PMC article. Review.
Cited by
-
The future of SARS-CoV-2 vaccines in transplant recipients: To be determined.Am J Transplant. 2021 Aug;21(8):2629-2630. doi: 10.1111/ajt.16598. Epub 2021 Apr 19. Am J Transplant. 2021. PMID: 33829628 Free PMC article.
-
Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.medRxiv [Preprint]. 2023 Jan 28:2023.01.25.23284971. doi: 10.1101/2023.01.25.23284971. medRxiv. 2023. Update in: ERJ Open Res. 2023 Oct 16;9(5):00400-2023. doi: 10.1183/23120541.00400-2023. PMID: 36747750 Free PMC article. Updated. Preprint.
-
Risk Factors Associated With an Impaired Antibody Response in Kidney Transplant Recipients Following 2 Doses of the SARS-CoV-2 mRNA Vaccine.Transplant Direct. 2021 Dec 13;8(1):e1257. doi: 10.1097/TXD.0000000000001257. eCollection 2022 Jan. Transplant Direct. 2021. PMID: 34912946 Free PMC article.
-
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era.Open Forum Infect Dis. 2021 Jun 30;8(7):ofab353. doi: 10.1093/ofid/ofab353. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34337100 Free PMC article.
-
Kidney Transplantation in Times of Covid-19: Decision Analysis in the Canadian Context.Can J Kidney Health Dis. 2021 Sep 14;8:20543581211040332. doi: 10.1177/20543581211040332. eCollection 2021. Can J Kidney Health Dis. 2021. PMID: 34540237 Free PMC article.
References
-
- Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020; 383:2439–2450
-
- Chavarot N, Leruez-Ville M, Scemla A, et al. Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection. Kidney Int. 2021; 99:486–488
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
